Aflibercept versus ranibizumab for cystoid macular oedema secondary to central retinal vein occlusion

被引：0
|
作者：
Karampelas, Michael [1 ]
Waxman, Jacob [1 ]
Barampouti, Foteini Faye [1 ]
机构：
[1] West Herts NHS Trust, Ophthalmol, London, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2018年 / 59卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
4286
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion
    Vasileios E. Konidaris
    Konstantinos T. Tsaousis
    Rossella Anzidei
    Guillermo de la Mata
    Alexander J. Brent
    Ophthalmology and Therapy, 2018, 7 : 387 - 395
  • [32] Real-World Results of Switching Treatment from Ranibizumab to Aflibercept in Macular Oedema Secondary to Branch Retinal Vein Occlusion
    Konidaris, Vasileios E.
    Tsaousis, Konstantinos T.
    Anzidei, Rossella
    de la Mata, Guillermo
    Brent, Alexander J.
    OPHTHALMOLOGY AND THERAPY, 2018, 7 (02) : 387 - 395
  • [33] Ranibizumab and aflibercept intravitreal injection for treatment naive and refractory macular oedema in branch retinal vein occlusion
    Hogg, H. D. Jeffry
    Di Simplicio, Sandro
    Pearce, Mark S.
    EUROPEAN JOURNAL OF OPHTHALMOLOGY, 2021, 31 (02) : 548 - 555
  • [34] Intravitreal Aflibercept (Eylea®): A Review of Its Use in Patients with Macular Oedema Secondary to Central Retinal Vein Occlusion
    Lily P. H. Yang
    Kate McKeage
    Drugs & Aging, 2014, 31 : 395 - 404
  • [35] Intravitreal Aflibercept (Eylea®): A Review of Its Use in Patients with Macular Oedema Secondary to Central Retinal Vein Occlusion
    Yang, Lily P. H.
    McKeage, Kate
    DRUGS & AGING, 2014, 31 (05) : 395 - 404
  • [36] The use of aflibercept in the management of macular edema secondary to central retinal vein occlusion
    Kim, Daniel Dae
    Saraf, Steven
    Desai, Ankit
    Desai, Uday
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2016, 57 (12)
  • [37] Effect of aflibercept on persistent macular edema secondary to central retinal vein occlusion
    Kaya, F.
    Kocak, I
    Aydin, A.
    Baybora, H.
    Koc, H.
    Karabela, Y.
    JOURNAL FRANCAIS D OPHTALMOLOGIE, 2018, 41 (09): : 809 - 813
  • [38] Azd-1222/tozinameranBranch retinal vein occlusion, central retinal vein occlusion and cystoid macular oedema: 5 case reports
    Reactions Weekly, 2022, 1915 (1) : 90 - 90
  • [39] Comparing Cytokine Kinetics between Ranibizumab and Aflibercept in Central Retinal Vein Occlusion with Macular Edema
    Kotake, Osamu
    Noma, Hidetaka
    Yasuda, Kanako
    Motohashi, Ryosuke
    Goto, Hiroshi
    Shimura, Masahiko
    OPHTHALMIC RESEARCH, 2019, 61 (04) : 210 - 217
  • [40] Two-year outcomes of intravitreal (IVT) ranibizumab for macular oedema secondary to branch retinal vein occlusion (BRVO) and central retinal vein occlusion (CRVO)
    Juma, Z.
    Tyagi, P.
    Santiago, C.
    Ionean, A.
    EYE, 2017, 31 : S16 - S16
12345